← 產業報告目錄
Cloud-based Pharma Manufacturing Software Market Size, Share & Trends Analysis Distribution by Deployment Type (Cloud-based (SaaS, PaaS, IaaS), Hybrid Cloud), Enterprise Size (Large Enterprises, Small and Medium Enterprises (SMEs)), Application (Production Management Systems (PMS), Enterprise Resource Planning (ERP), Quality Management Systems (QMS), Manufacturing Execution Systems (MES), Others (Regulatory Compliance, LIMS, PAT)), End-User (Pharmaceutical Companies, Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs)) and Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-22頁數 180報告編號 INSIGHTACE-90f0a4095e
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Cloud-based Pharma Manufacturing Software Market is positioned for steady expansion, with a projected CAGR of 14.8% from 2025 to 2034.
The Cloud-based Pharma Manufacturing Software sector involves is revolutionizing the pharmaceutical sector through scalable, affordable solutions that automate production and meet compliance requirements. This domain has witnessed meaningful transformation owing to technological breakthroughs and shifting healthcare dynamics.
Growth is supported by a convergence of factors: rising awareness among end users, continuous product innovation, and the escalating emphasis on efficiency and sustainability within the healthcare sector.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, supported by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cloud-based Pharma Manufacturing Software Market Snapshot
Chapter 4. Global Cloud-based Pharma Manufacturing Software Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Cloud-based Pharma Manufacturing Software Market Industry Trends
4.10. Global Cloud-based Pharma Manufacturing Software Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Cloud-based Pharma Manufacturing Software Market Segmentation 1: By Deployment Type, Estimates & Trend Analysis
5.1. Market Share by Radioactive Deployment Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Radioactive Deployment Type:
5.2.1. Cloud-based (SaaS, PaaS, IaaS)
5.2.2. Hybrid Cloud
Chapter 6. Cloud-based Pharma Manufacturing Software Market Segmentation 2: By Enterprise Size, Estimates & Trend Analysis
6.1. Market Share by Enterprise Size, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Enterprise Size:
6.2.1. Large Enterprises
6.2.2. Small and Medium Enterprises (SMEs)
Chapter 7. Cloud-based Pharma Manufacturing Software Market Segmentation 3: By Application, Estimates & Trend Analysis
7.1. Market Share by Application, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
7.2.1. Production Management Systems (PMS)
7.2.2. Enterprise Resource Planning (ERP)
7.2.3. Quality Management Systems (QMS)
7.2.4. Manufacturing Execution Systems (MES)
7.2.5. Others (Regulatory Compliance, LIMS, PAT)
Chapter 8. Cloud-based Pharma Manufacturing Software Market Segmentation 4: By End-user, Estimates & Trend Analysis
8.1. Market Share by End-user, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-user:
8.2.1. Pharmaceutical Companies
8.2.2. Biopharmaceutical Companies
8.2.3. Contract Manufacturing Organizations (CMOs)
8.2.4. Others (Medical Device Manufacturers, CROs, Academic Institutions)
Chapter 9. Cloud-based Pharma Manufacturing Software Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Cloud-based Pharma Manufacturing Software Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Deployment Type, 2021-2034
9.2.3. North America Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Enterprise Size, 2021-2034
9.2.4. North America Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.5. North America Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.3. Europe
9.3.1. Europe Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Deployment Type, 2021-2034
9.3.3. Europe Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Enterprise Size, 2021-2034
9.3.4. Europe Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.5. Europe Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Southeast Asia
9.4.1.7. Rest of Asia Pacific
9.4.2. Asia Pacific Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Deployment Type, 2021-2034
9.4.3. Asia Pacific Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Enterprise Size, 2021-2034
9.4.4. Asia Pacific Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.4.5. Asia Pacific Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.5. Latin America
9.5.1. Latin America Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Deployment Type, 2021-2034
9.5.3. Latin America Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Enterprise Size, 2021-2034
9.5.4. Latin America Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.5. Latin America Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. South Africa
9.6.1.3. Rest of Middle East and Africa
9.6.2. Middle East & Africa Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Deployment Type, 2021-2034
9.6.3. Middle East & Africa Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Enterprise Size, 2021-2034
9.6.4. Middle East & Africa Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.6.5. Middle East & Africa Cloud-based Pharma Manufacturing Software Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Amazon Web Services (AWS)
10.2.1.1. Business Overview
10.2.1.2. Key Solution/Service Overview
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Microsoft Azure
10.2.3. Google Cloud
10.2.4. Oracle
10.2.5. SAP SE
10.2.6. Veeva Systems Inc.
10.2.7. MasterControl Inc.
10.2.8. BatchMaster Software
10.2.9. Werum IT Solutions GmbH (Körber AG)
10.2.10. Aspen Technology Inc.
10.2.11. Siemens AG
10.2.12. Rockwell Automation Inc.
10.2.13. Honeywell International Inc.
10.2.14. Emerson Electric Co.
10.2.15. Kinaxis Inc.
10.2.16. Sparta Systems Inc.
10.2.17. Pegasystems Inc.
10.2.18. MRPeasy
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們